There was a time when the decision to offshore manufacturing operations to an emerging market was an easy business decision. However, the past decade has many companies questioning that business model. Rising labor costs, uncertain supply chains, labor unrest and the costly and lengthy delivery time for manufactured goods coming from Asia has exponentially increased the cost to offshore manufacturing.
October 2013
Draft of Rules of the China Food and Drug Administration: Legislative Procedures Opened for Public Comment
By Zheng Xie, Robert Stang & Carlos Rodriguez on
On Aug 5, 2013, the China Food and Drug Administration (CFDA) opened its draft Rules of the China Food and Drug Administration Legislation Procedure (the “Draft”) for public comment. The CFDA provided one month (August 5-September 5) to submit opinions on the new rules in the Draft. The Draft states the purposes of the new Rules are to regulate legislative procedures, guarantee the quality of legislation, and improve the efficiency of the legislation.